|
業務類別
|
Biotechnology |
|
業務概覽
|
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP. |
| 公司地址
| 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462 |
| 電話號碼
| +1 267 440-4200 |
| 傳真號碼
| +1 267 440-4242 |
| 公司網頁
| https://www.inovio.com |
| 員工數量
| 112 |
| Mr. Peter D. Kies |
Chief Financial Officer and Principal Accounting Officer |
美元 514.60K |
07/04/2026 |
| Dr. Laurent M. Humeau, PhD |
Chief Scientific Officer |
-- |
07/04/2026 |
| Dr. Jacqueline E. Shea, PhD |
President, Chief Executive Officer and Director |
美元 728.00K |
07/04/2026 |
| Dr. Michael John Sumner, M.D. |
Chief Medical Officer and Head of Development |
美元 548.71K |
07/04/2026 |
|
|
| Ms. Lota S. Zoth, C.P.A. |
Independent Director |
07/04/2026 |
| Mr. Simon X. Benito |
Chairman of the Board |
07/04/2026 |
| Ms. Wendy L. Yarno, M.B.A. |
Independent Director |
07/04/2026 |
| Mr. Jay P. Shepard |
Independent Director |
07/04/2026 |
| Dr. David B. Weiner, PhD |
Director |
07/04/2026 |
| Dr. Roger D. Dansey, M.D. |
Independent Director |
07/04/2026 |
| Dr. Jacqueline E. Shea, PhD |
President, Chief Executive Officer and Director |
07/04/2026 |
| Dr. Ann C. Miller, M.D. |
Independent Director |
07/04/2026 |
|
|
|
|
